Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The association of genetic polymorphisms with neuroconnectivity in breast cancer patients.

Scientific reports - 17 Mar 2021

Harrison Rebecca A, Rao Vikram, Kesler Shelli R

Abstract excerpt

Genetic polymorphisms in select genes, including APOE (apolipoprotein E), COMT (Catechol-O-Methyltransferase), MDR1 (multi-drug resistance 1), BDNF (brain derived neurotrophic factor), and GST (glutathione-S-transferase), have been associated with vulnerability to cognitive impairment. In this study, we evaluated the relationship of these genetic variants to measures of brain health in patients with breast...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Biomarkers, Tumor
Share to Breast Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cognitive Dysfunction

Share to BDNF gene

Share to COMT gene

Share to Genetic Predisposition to Disease

Share to Polymorphism, Single Nucleotide

Source

Open in PubMed Open full text

Identifiers

PMID: 33731765
DOI: 10.1038/s41598-021-85768-4
PMCID: PMC7971072

Genes

APOE
BDNF
COMT

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The association of genetic polymorphisms with neuroconnectivity in breast cancer patients.PMID 33731765Read ↗

Genetic variants and cognitive functions in patients with brain tumorsSemantic proximity Read ↗

Catechol-O-methyltransferase genotype modulates cancer treatment-related cognitive deficits in breast cancer survivors.Semantic proximity Read ↗

Catechol-O-Methyltransferase Gene Polymorphisms and the Risk of Chemotherapy-Induced Prospective Memory Impairment in Breast Cancer Patients with Varying Tumor Hormonal Receptor Expression.Semantic proximity Read ↗

Genetic variants associated with longitudinal cognitive performance in older breast cancer patients and controlsSemantic proximity Read ↗

COMT, BDNF, and DTNBP1 polymorphisms and cognitive functions in patients with brain tumors.Semantic proximity Read ↗

Brain-derived neurotrophic factor genetic polymorphism (rs6265) is protective against chemotherapy-associated cognitive impairment in patients with early-stage breast cancer.Semantic proximity Read ↗

The COMT Rs737865 Mediates Chemo-Brain In Breast Cancer Patients With Various Index Of Ki-67Semantic proximity Read ↗

Association of COMT haplotypes and breast cancer risk in caucasian women.Semantic proximity Read ↗

Genetic Modulation of Neurocognitive Function in Glioma Patients.Semantic proximity Read ↗

Exploratory Study of Associations Between DNA Repair and Oxidative Stress Gene Polymorphisms and Cognitive Problems Reported by Postmenopausal Women With and Without Breast Cancer.Semantic proximity Read ↗

Variations in COMT and NTRK2 Influence Symptom Burden in Women Undergoing Breast Cancer Treatment.Semantic proximity Read ↗

Associations between catechol-O-methyltransferase (COMT) genotypes at rs4818 and rs4680 and gene expression in human dorsolateral prefrontal cortex.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.